硕肯生物硕肯生物Soken.bio
查看试用产品 →开放浏览 · 登录后申请
抗人 TNFSF11 抗体对
试剂盒

抗人 TNFSF11 抗体对

01AB01385

TNF superfamily member 11 (TNFSF11), also known as Tumor necrosis factor ligand superfamily member 11, is a member of the TNF cytokine family that functions as a key regulator in various biological processes. It serves as a ligand for osteoprotegerin and plays a crucial role in osteoclast differentiation and activation. TNFSF11 acts as a dendritic cell survival factor and regulates T-cell-dependent immune responses, with T cell activation inducing its expression. The protein enables identical protein binding activity, receptor ligand activity, and tumor necrosis factor receptor superfamily binding. TNFSF11 activates the antiapoptotic kinase AKT/PKB through a signaling complex involving SRC kinase and TRAF6, suggesting a role in cell apoptosis regulation. Regarding disease associations, disruption of TNFSF11 in mice results in severe osteopetrosis and absence of osteoclasts, along with defects in early T and B lymphocyte differentiation. Additionally, TNFSF11 overexpression can lead to increased osteoclastogenesis and bone loss, making it a significant factor in bone-related disorders.

Human
规格起售价
登录后可查看

技术参数

靶点基因名
TNFSF11
基因别名
OPGL; RANKL; TRANCE
蛋白别名
TNF superfamily member 11; TNFSF11
UniProt
O14788
物种
Human

产品详情

靶点名称
TNFSF11
蛋白名称
TNF superfamily member 11
蛋白别名
Tumor necrosis factor ligand superfamily member 11; Osteoclast differentiation factor; ODF; Osteoprotegerin ligand; OPGL; Receptor activator of nuclear factor kappa-B ligand; RANKL; TNF-related activation-induced cytokine; TRANCE; CD antigen CD254) [Cleaved into: Tumor necrosis factor ligand superfamily member 11; membrane form; Tumor necrosis factor ligand superfamily member 11; soluble form]
靶点基因名
TNFSF11
基因别名
OPGL; RANKL; TRANCE
UniProt
O14788
来源物种
Homo sapiens (Human)
物种反应性
Human

背景介绍

TNF superfamily member 11 (TNFSF11), also known as Tumor necrosis factor ligand superfamily member 11, is a member of the TNF cytokine family that functions as a key regulator in various biological processes. It serves as a ligand for osteoprotegerin and plays a crucial role in osteoclast differentiation and activation. TNFSF11 acts as a dendritic cell survival factor and regulates T-cell-dependent immune responses, with T cell activation inducing its expression. The protein enables identical protein binding activity, receptor ligand activity, and tumor necrosis factor receptor superfamily binding. TNFSF11 activates the antiapoptotic kinase AKT/PKB through a signaling complex involving SRC kinase and TRAF6, suggesting a role in cell apoptosis regulation. Regarding disease associations, disruption of TNFSF11 in mice results in severe osteopetrosis and absence of osteoclasts, along with defects in early T and B lymphocyte differentiation. Additionally, TNFSF11 overexpression can lead to increased osteoclastogenesis and bone loss, making it a significant factor in bone-related disorders.